What is Nexstim?
Nexstim operates at the intersection of advanced engineering and clinical neuroscience, focusing on the development of navigated transcranial magnetic stimulation (nTMS) technology. The company's core value proposition lies in its sophisticated 3D navigation software, which enables clinicians to achieve highly accurate, personalized targeting of brain regions. This precision is critical for both the Diagnostics Business, which provides FDA-cleared pre-surgical mapping of speech and motor cortices, and the Therapy Business, which offers NBT systems for treating major depressive disorder and chronic neuropathic pain. By bridging the gap between complex brain diagnostics and targeted therapeutic intervention, Nexstim maintains a unique competitive advantage in the global neurotechnology landscape.
How much funding has Nexstim raised?
Nexstim has raised a total of $5.3M across 2 funding rounds:
Debt
$4.7M
Other Financing Round
$564K
Debt (2017): $4.7M with participation from Kreos Capital
Other Financing Round (2022): $564K led by PNC Management & Investments
Key Investors in Nexstim
Kreos Capital
Kreos Capital Group Ltd is a company that specializes in finance. It provides investment services and business management. The company was formed in 1998 and is headquartered in London, United Kingdom.
PNC Management & Investments
PNC Management & Investments LLC is a real estate investment firm that specializes in flipping foreclosure.
What's next for Nexstim?
With the recent infusion of capital, Nexstim is poised to deepen its market penetration in the United States and Europe. The strategic focus will likely shift toward expanding the clinical adoption of its NBT systems for major depressive disorder, while simultaneously enhancing the diagnostic capabilities of its NBS platform. As the company scales, it will prioritize regulatory compliance and the expansion of its clinical evidence base to support broader insurance reimbursement and physician adoption. This phase of growth is critical for Nexstim as it seeks to solidify its status as a leader in personalized brain health solutions, ensuring that its non-invasive technologies become a standard of care for patients suffering from complex neurological and psychiatric disorders.
See full Nexstim company page
